Interleukin-13 Receptor Alpha 2-Targeted Glioblastoma Immunotherapy

Table 3

Chimeric antigen receptors targeting GBM.

GBM targets	Preclinical studies	Clinical trials
EGFRvIII	[68–70]	NCT01454596 [71]
EphA2	[72]	None
HER2	[73]	NCT01109095 [74]
IL13Rα2	[22, 23, 39–41]	NCT00730613 [37]; NCT01082926 [38]